1. Home
  2. CASI vs EBON Comparison

CASI vs EBON Comparison

Compare CASI & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • EBON
  • Stock Information
  • Founded
  • CASI 1991
  • EBON 2010
  • Country
  • CASI China
  • EBON China
  • Employees
  • CASI N/A
  • EBON 303
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • EBON Semiconductors
  • Sector
  • CASI Health Care
  • EBON Technology
  • Exchange
  • CASI Nasdaq
  • EBON Nasdaq
  • Market Cap
  • CASI 33.4M
  • EBON 21.2M
  • IPO Year
  • CASI 1996
  • EBON 2020
  • Fundamental
  • Price
  • CASI $1.94
  • EBON $3.33
  • Analyst Decision
  • CASI Strong Buy
  • EBON
  • Analyst Count
  • CASI 1
  • EBON 0
  • Target Price
  • CASI $4.00
  • EBON N/A
  • AVG Volume (30 Days)
  • CASI 13.6K
  • EBON 6.5K
  • Earning Date
  • CASI 05-13-2025
  • EBON 04-25-2025
  • Dividend Yield
  • CASI N/A
  • EBON N/A
  • EPS Growth
  • CASI N/A
  • EBON N/A
  • EPS
  • CASI N/A
  • EBON N/A
  • Revenue
  • CASI $28,537,000.00
  • EBON $3,591,648.00
  • Revenue This Year
  • CASI $66.12
  • EBON N/A
  • Revenue Next Year
  • CASI $51.37
  • EBON N/A
  • P/E Ratio
  • CASI N/A
  • EBON N/A
  • Revenue Growth
  • CASI N/A
  • EBON N/A
  • 52 Week Low
  • CASI $1.88
  • EBON $3.00
  • 52 Week High
  • CASI $7.67
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • CASI 41.12
  • EBON 36.07
  • Support Level
  • CASI $1.91
  • EBON $3.25
  • Resistance Level
  • CASI $2.14
  • EBON $3.50
  • Average True Range (ATR)
  • CASI 0.20
  • EBON 0.25
  • MACD
  • CASI -0.01
  • EBON 0.02
  • Stochastic Oscillator
  • CASI 11.11
  • EBON 30.00

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.

Share on Social Networks: